The addition of Blue Spark Technologies, Inc. and QT Medical as device partners signals exciting growth for HeartcoR Solutions as a leading core lab for remote patient monitoring (RPM)

SCHAUMBURG, Ill., Sept. 18, 2025 /PRNewswire/ -- HeartcoR Solutions, a leading core lab focused on the collection, analysis, and reporting of cardiac safety and other physiological data in clinical trials, announced today exciting growth in its suite of remote monitoring technology. The addition of the TempTraq^® device from Blue Spark Technologies, Inc., and the PCA 500 from QT Medical allows HeartcoR to create a one-stop shop for clinical trial sponsors. 

"Healthcare innovation relies on the ability to prove the safety and efficacy of new medical devices and therapeutics," said Ciaran Cooper, CEO of HeartcoR Solutions. "By expanding our suite of remote monitoring devices, we're empowering clinical trial sponsors to save time and streamline workflows by sourcing all of their device needs through one partner, HeartcoR Solutions."

The rising demand for more inclusive, patient-centric healthcare, including increased convenience and access, has led the pharmaceutical and medical device industries to seek out a growing number of remote monitoring solutions when collecting vital data on the safety and efficacy of innovative, new interventions in clinical trials.

The global RPM market is projected to grow at a CAGR of 19.8% from 2025 to 2033. This reflects an unprecedented number of new devices reaching the market over the next several years, ranging from consumer-based at-home monitoring devices to sophisticated patches worn under physician supervision for a range of physiological measurements. To capitalize on this opportunity, clinical trial sponsors must be able to efficiently source devices for different physiological measures. By expanding its suite of RPM devices, HeartcoR Solutions aims to improve access to and convenience for subjects in clinical trials, thus ultimately driving better data while streamlining processes and reducing overall trial costs.

The Newest Additions to HeartcoR's Technology Suite

• The TempTraq^® from Blue Spark Technologies, Inc. is an FDA-cleared, Class II medical device that delivers continuous, real-time body temperature monitoring, which can signal an early change in health status or the body's response to treatment. This one-time-use device has an operating life of 72 hours and connects wirelessly via Bluetooth, allowing patients to move about freely. TempTraq^® data integrates with EHRs and remote patient monitoring platforms to deliver a more complete picture of patient health for clinical trials.
• The PCA 500 from QT Medical is a hospital-quality, 12-lead ECG device that can be easily applied by the patient at home or at a clinical trial testing site. The PCA 500 kit includes a compact recorder; QT Medical's patented, preconnected, and prepositioned electrode strips (QHeart sensor); a user-friendly mobile app; and HIPAA-compliant cloud dashboard for data transfer and management. The device has a rechargeable battery, is lightweight, and connects wirelessly to a Bluetooth device for easy ECG data acquisition and transmission.

"Our team at HeartcoR Solutions is committed to driving medical innovation through the core lab services we provide. And by expanding our technology suite with cutting-edge devices that are patient-centered and proven to deliver high-quality, reliable data, we're doing just that," said Cooper.

To learn more about HeartcoR Solutions or to schedule a meeting to discuss specific clinical trial needs, visit www.HeartcoRSolutions.com.

HeartcoR Solutions LLC, headquartered in the Chicago area, is a leading core lab focused on the collection, analysis, and reporting of cardiac safety and other physiological data in clinical trials. Learn more at www.heartcorsolutions.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/heartcor-solutions-expands-suite-of-remote-patient-monitoring-devices-creating-a-one-stop-shop-for-clinical-trial-partners-302560569.html

SOURCE HeartcoR Solutions